We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+5.29%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$39.5B
AUM Growth
+$3.17B
Cap. Flow
+$1.77B
Cap. Flow %
4.5%
Top 10 Hldgs %
14.6%
Holding
2,920
New
47
Increased
1,798
Reduced
994
Closed
66

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$26.1M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$22M
3
AAPL icon
Apple
AAPL
+$20.6M
4
MSFT icon
Microsoft
MSFT
+$18.3M
5
T icon
AT&T
T
+$15.4M

Sector Composition

Rank Sector Weight
1 Financials 16.57%
2 Technology 14.46%
3 Healthcare 12.77%
4 Industrials 10.91%
5 Consumer Discretionary 9.17%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PMTS icon
2826
CPI Card Group
PMTS
$242M
$52K ﹤0.01%
2,488
-437
-15% -$10K
VSLR
2827
DELISTED
VIVINT SOLAR, INC.
VSLR
$49K ﹤0.01%
19,270
-4,520
-19% -$13.5K
LPCN icon
2828
Lipocine
LPCN
$17.5M
$46K ﹤0.01%
737
-319
-30% -$20.2K
TOVX icon
2829
Theriva Biologics
TOVX
$9.64M
$46K ﹤0.01%
7
-2
-22% -$20.5K
LUB
2830
DELISTED
Luby's Inc.
LUB
$46K ﹤0.01%
10,842
-133
-1% -$563
APVO icon
2831
Aptevo Therapeutics
APVO
$5.12M
0
FCEL icon
2832
FuelCell Energy
FCEL
$1.73B
$44K ﹤0.01%
70
-21
-23% -$24.5K
FLNT
2833
Fluent
FLNT
$102M
$44K ﹤0.01%
2,130
-1,922
-47% -$41.6K
AVGR
2834
DELISTED
Avinger, Inc. Common Stock
AVGR
0
DMTX
2835
DELISTED
Dimension Therapeutics, Inc
DMTX
$44K ﹤0.01%
10,027
-1,748
-15% -$9.3K
AGFS
2836
DELISTED
AgroFresh Solutions Inc
AGFS
$35K ﹤0.01%
13,141
-84
-0.6% -$310
ERN
2837
DELISTED
Erin Energy Corp
ERN
$35K ﹤0.01%
11,340
UONEK icon
2838
Urban One Class D
UONEK
$22.8M
$34K ﹤0.01%
1,182
-1,407
-54% -$39.1K
TNDM icon
2839
Tandem Diabetes Care
TNDM
$1.34B
$33K ﹤0.01%
1,549
-105
-6% -$4.04K
AMPE
2840
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$31K ﹤0.01%
113
-36
-24% -$8.57K
ANTH
2841
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
$22K ﹤0.01%
4,310
-2,777
-39% -$48.1K
CYTR
2842
DELISTED
CytRx Corp
CYTR
$22K ﹤0.01%
10,070
-4,807
-32% -$14.1K
CVRS
2843
DELISTED
CORINDUS VASCULAR ROBOTICS, INC
CVRS
$21K ﹤0.01%
30,627
-895
-3% -$753
VANI icon
2844
Vivani Medical
VANI
$110M
$20K ﹤0.01%
430
-525
-55% -$30K
CBR
2845
DELISTED
CIBER Inc.
CBR
$13K ﹤0.01%
20,636
+3,110
+18% +$2.68K
ULU
2846
DELISTED
ULURU INC COM STK NEW (NV)
ULU
$1K ﹤0.01%
22,000
BND icon
2847
Vanguard Total Bond Market
BND
$157B
-18,688
Closed -$1.57M
CIVI
2848
DELISTED
Civitas Resources
CIVI
-324
Closed -$37K
GAIA icon
2849
Gaia
GAIA
$46.8M
-10,234
Closed -$74K
GWRS icon
2850
Global Water Resources
GWRS
$206M
-11,140
Closed -$89K

Similar funds

RhumbLine Advisers's Q4 2016 Portfolio in Review

As of Q4 2016, RhumbLine Advisers held 2,920 positions worth $39.5B, up 8.7% from $36.3B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

RhumbLine Advisers deployed $1.77B of net new capital in Q4 2016, opening 47 new positions and adding to 1,798 existing holdings. Its largest new stake was Howmet Aerospace: 952,104 shares worth $13.5M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

On the sell side, the largest reduction was Procter & Gamble, an estimated $21.2M trimmed.

  • RhumbLine Advisers's largest Q4 2016 buy was Howmet Aerospace: 952,104 shares worth $13.5M.
  • RhumbLine Advisers added most to ExxonMobil in Q4 2016, an estimated $26.1M increase.
  • RhumbLine Advisers's biggest Q4 2016 reduction was Procter & Gamble, cutting an estimated $21.2M.
  • RhumbLine Advisers fully exited LinkedIn Corporation in Q4 2016, selling an estimated $24.4M.
  • RhumbLine Advisers's ten largest holdings make up 15% of its $39.5B portfolio in Q4 2016.
  • RhumbLine Advisers opened 47 new positions and closed 66 in Q4 2016.
  • RhumbLine Advisers's portfolio value rose 8.7% quarter-over-quarter to $39.5B.

Based on RhumbLine Advisers's 13F filing for Q4 2016, filed 27 Jan 2017.